Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionHLA-A specific inhibitory MHC class I receptor activity

LILRA1 LILRA2

5.63e-055482GO:0030107
GeneOntologyMolecularFunctionHLA-B specific inhibitory MHC class I receptor activity

LILRA1 LILRA2

8.44e-056482GO:0030109
GeneOntologyMolecularFunctionMHC class Ib protein complex binding

LILRA1 LILRA2

1.18e-047482GO:0023025
GeneOntologyMolecularFunctionIgM binding

LILRA1 LILRA2

3.07e-0411482GO:0001791
GeneOntologyMolecularFunctioninhibitory MHC class I receptor activity

LILRA1 LILRA2

3.68e-0412482GO:0032396
GeneOntologyMolecularFunction3'-5' exonuclease activity

EXD3 CNOT6L CNOT1

4.25e-0461483GO:0008408
GeneOntologyMolecularFunctionpoly(A)-specific ribonuclease activity

CNOT6L CNOT1

4.34e-0413482GO:0004535
GeneOntologyMolecularFunctionMHC class Ib protein binding

LILRA1 LILRA2

6.65e-0416482GO:0023029
GeneOntologyMolecularFunctionMHC class I receptor activity

LILRA1 LILRA2

8.45e-0418482GO:0032393
GeneOntologyMolecularFunctionMHC class Ib receptor activity

LILRA1 LILRA2

9.43e-0419482GO:0032394
GeneOntologyMolecularFunctionexonuclease activity

EXD3 CNOT6L CNOT1

1.41e-0392483GO:0004527
GeneOntologyCellularComponentFc-epsilon receptor I complex

LILRA1 LILRA2

1.92e-049492GO:0032998
GeneOntologyCellularComponentFc receptor complex

LILRA1 LILRA2

3.50e-0412492GO:0032997
GeneOntologyCellularComponentCCR4-NOT complex

CNOT6L CNOT1

6.33e-0416492GO:0030014
HumanPhenoAplasia/Hypoplasia of the phalanges of the thumb

VPS35L ACVR1 PTCH1 CNOT1

1.62e-0546184HP:0009658
MousePhenoabnormal snout morphology

FREM2 EPS8L2 KMT2D COL11A2 DSG3 APAF1 CYB561

4.20e-06257377MP:0000443
DomainA1B_glyco/leuk_Ig-like_rcpt

LILRA1 LILRA2 LILRA6

3.38e-076493IPR016332
DomainCNH

CDC42BPA MAP4K1

6.01e-0414492SM00036
DomainCNH

CDC42BPA MAP4K1

6.93e-0415492PF00780
DomainCNH

CDC42BPA MAP4K1

6.93e-0415492PS50219
DomainCNH_dom

CDC42BPA MAP4K1

6.93e-0415492IPR001180
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

ANKRD44 EXD3 CDC42BPA SLC16A14 VPS35L ANKRD17 MICAL3 TECTA KCNIP3 MMP16 CNOT1 SH3YL1

9.71e-071489501228611215
Pubmed

Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis.

LILRA1 LILRA2

2.03e-06250218273033
Pubmed

Nonsyndromic hearing impairment: unparalleled heterogeneity.

COL11A2 TECTA

2.03e-0625029106521
Pubmed

Genetic interaction mapping in mammalian cells using CRISPR interference.

PHC3 KMT2D CNOT1 MEN1

3.05e-066950428481362
Pubmed

Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma.

KMT2D PTCH1

6.07e-06350222183980
Pubmed

Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.

KMT2D MEN1

6.07e-06350230315824
Pubmed

Holoprosencephaly Overview

KMT2D PTCH1 CNOT1

6.29e-062550320301702
Pubmed

Research progress in pathogenic genes of hereditary non-syndromic mid-frequency deafness.

COL11A2 TECTA

1.21e-05450227142990
Pubmed

Plasticity in the organization and sequences of human KIR/ILT gene families.

LILRA1 LILRA2

1.21e-05450210781084
Pubmed

PirB regulates a structural substrate for cortical plasticity.

LILRA1 LILRA2

2.02e-05550224302763
Pubmed

Spatio-temporal expression of paired immunoglobulin-like receptor-B in the adult mouse brain after focal cerebral ischaemia.

LILRA1 LILRA2

2.02e-05550223927735
Pubmed

Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.

LILRA1 LILRA2

2.02e-05550218787130
Pubmed

Enhancing motor learning by increasing the stability of newly formed dendritic spines in the motor cortex.

LILRA1 LILRA2

2.02e-05550234437845
Pubmed

Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus.

LILRA1 LILRA2

2.02e-05550237147336
Pubmed

Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.

LILRA1 LILRA2

2.02e-05550233653799
Pubmed

PIR-B Regulates CD4+ IL17a+ T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses.

LILRA1 LILRA2

2.02e-05550234242819
Pubmed

Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury.

LILRA1 LILRA2

2.02e-05550221087927
Pubmed

Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis.

LILRA1 LILRA2

2.02e-05550220398663
Pubmed

Structure and flexibility of the extracellular region of the PirB receptor.

LILRA1 LILRA2

2.02e-05550230674550
Pubmed

Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence.

LILRA1 LILRA2

2.02e-05550223152562
Pubmed

Regulation of plasmacytoid dendritic cell responses by PIR-B.

LILRA1 LILRA2

2.02e-05550222948046
Pubmed

Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors.

LILRA1 LILRA2

2.02e-0555029054430
Pubmed

p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation.

KMT2D MEN1

2.02e-05550218026121
Pubmed

Role of PIR-B in autoimmune glomerulonephritis.

LILRA1 LILRA2

2.02e-05550220976309
Pubmed

Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.

LILRA1 LILRA2

2.02e-05550210359805
Pubmed

The structural basis for the interaction between the CAF1 nuclease and the NOT1 scaffold of the human CCR4-NOT deadenylase complex.

CNOT6L CNOT1

2.02e-05550222977175
Pubmed

Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.

LILRA1 LILRA2

2.02e-05550227324131
Pubmed

Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury.

LILRA1 LILRA2

2.02e-05550220881122
Pubmed

Characterization of paired Ig-like receptors in rats.

LILRA1 LILRA2

2.02e-05550210586026
Pubmed

Paired immunoglobulin-like receptor B regulates platelet activation.

LILRA1 LILRA2

2.02e-05550225075127
Pubmed

Genomic structure of PIR-B, the inhibitory member of the paired immunoglobulin-like receptor genes in mice.

LILRA1 LILRA2

2.02e-0555029550322
Pubmed

Expression of PirB protein in intact and injured optic nerve and retina of mice.

LILRA1 LILRA2

2.02e-05550222102155
Pubmed

Paired immunoglobulin-like receptors and their MHC class I recognition.

LILRA1 LILRA2

2.02e-05550216011512
Pubmed

PirB Overexpression Exacerbates Neuronal Apoptosis by Inhibiting TrkB and mTOR Phosphorylation After Oxygen and Glucose Deprivation Injury.

LILRA1 LILRA2

2.02e-05550227443384
Pubmed

Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.

LILRA1 LILRA2

2.02e-05550223258232
Pubmed

MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.

KMT2D MEN1

2.02e-05550228609655
Pubmed

The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling.

LILRA1 LILRA2

2.02e-05550215494528
Pubmed

Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses.

LILRA1 LILRA2

2.02e-05550219684158
Pubmed

Mast cell regulation via paired immunoglobulin-like receptor PIR-B.

LILRA1 LILRA2

2.02e-05550212403357
Pubmed

PirB negatively regulates the inflammatory activation of astrocytes in a mouse model of sleep deprivation.

LILRA1 LILRA2

2.02e-05550237146940
Pubmed

PirB functions as an intrinsic suppressor in hippocampal neural stem cells.

LILRA1 LILRA2

2.02e-05550234120891
Pubmed

Exacerbated graft-versus-host disease in Pirb-/- mice.

LILRA1 LILRA2

3.03e-05650215146181
Pubmed

PIR-B-deficient mice are susceptible to Salmonella infection.

LILRA1 LILRA2

3.03e-05650218768880
Pubmed

CAMKs support development of acute myeloid leukemia.

LILRA1 LILRA2

3.03e-05650229482582
Pubmed

Autoimmune arthritis induces paired immunoglobulin-like receptor B expression on CD4+ T cells from SKG mice.

LILRA1 LILRA2

3.03e-05650228664612
Pubmed

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis.

LILRA1 LILRA2

3.03e-05650237481670
Pubmed

Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity.

LILRA1 LILRA2

3.03e-05650231727773
Pubmed

Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT complex in mRNA regulation and cell viability.

CNOT6L CNOT1

3.03e-05650231924127
Pubmed

Blocking PirB up-regulates spines and functional synapses to unlock visual cortical plasticity and facilitate recovery from amblyopia.

LILRA1 LILRA2

3.03e-05650225320232
Pubmed

HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor.

LILRA1 LILRA2

3.03e-05650212207326
Pubmed

Cell-Autonomous Regulation of Dendritic Spine Density by PirB.

LILRA1 LILRA2

3.03e-05650227752542
Pubmed

Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.

LILRA1 LILRA2

3.03e-05650230787106
Pubmed

The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.

LILRA1 LILRA2

3.03e-0565029824165
Pubmed

CaSSiDI: novel single-cell "Cluster Similarity Scoring and Distinction Index" reveals critical functions for PirB and context-dependent Cebpb repression.

LILRA1 LILRA2

3.03e-05650238383888
Pubmed

Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway.

LILRA1 LILRA2

3.03e-05650239095838
Pubmed

PirB is a functional receptor for myelin inhibitors of axonal regeneration.

LILRA1 LILRA2

3.03e-05650218988857
Pubmed

MLL associates specifically with a subset of transcriptionally active target genes.

KMT2D MEN1

3.03e-05650216199523
Pubmed

Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells.

LILRA1 LILRA2

3.03e-05650221636572
Pubmed

Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity.

LILRA1 LILRA2

3.03e-05650227402837
Pubmed

Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation.

LILRA1 LILRA2

3.03e-05650224040397
Pubmed

PirB regulates asymmetries in hippocampal circuitry.

LILRA1 LILRA2

3.03e-05650228594961
Pubmed

The p75 receptor mediates axon growth inhibition through an association with PIR-B.

LILRA1 LILRA2

3.03e-05650221881600
Pubmed

Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development.

LILRA1 LILRA2

3.03e-05650224212998
Pubmed

Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B.

LILRA1 LILRA2

3.03e-05650230068593
Pubmed

Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice.

LILRA1 LILRA2

3.03e-05650212021780
Pubmed

Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.

LILRA1 LILRA2

4.23e-05750219658091
Pubmed

LOTUS suppresses amyloid β-induced dendritic spine elimination through the blockade of amyloid β binding to PirB.

LILRA1 LILRA2

4.23e-05750236510132
Pubmed

Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.

LILRA1 LILRA2

4.23e-05750219687229
Pubmed

Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.

LILRA1 LILRA2

4.23e-05750217998301
Pubmed

PirB restricts ocular-dominance plasticity in visual cortex.

LILRA1 LILRA2

4.23e-05750216917027
Pubmed

The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling.

LILRA1 LILRA2

4.23e-05750224278366
Pubmed

A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils.

LILRA1 LILRA2

4.23e-05750218316626
Pubmed

Macrophage Paired Immunoglobulin-Like Receptor B Deficiency Promotes Peripheral Atherosclerosis in Apolipoprotein E-Deficient Mice.

LILRA1 LILRA2

4.23e-05750235321392
Pubmed

Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity.

LILRA1 LILRA2

4.23e-05750220844138
Pubmed

NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1.

LILRA1 LILRA2

4.23e-05750227897222
Pubmed

Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production.

LILRA1 LILRA2

4.23e-05750217371981
Pubmed

Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3.

LILRA1 LILRA2

4.23e-05750221555536
Pubmed

Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.

LILRA1 LILRA2

5.64e-05850222660330
Pubmed

The absence of Hck, Fgr, and Lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.

LILRA1 LILRA2

5.64e-05850219255189
Pubmed

A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.

LILRA1 LILRA2

5.64e-0585029548455
Pubmed

Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family.

LILRA1 LILRA2

5.64e-0585029538215
Pubmed

Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells.

LILRA1 LILRA2

5.64e-05850221376641
Pubmed

An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR).

LILRA1 LILRA2

5.64e-05850218209065
Pubmed

NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation.

LILRA1 LILRA2

5.64e-05850224449409
Pubmed

VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells.

LILRA1 LILRA2

5.64e-05850235210567
Pubmed

Apaf1 apoptotic function critically limits Sonic hedgehog signaling during craniofacial development.

APAF1 PTCH1

7.25e-05950223892366
Pubmed

Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.

LILRA1 LILRA2

7.25e-05950217420263
Pubmed

Distinct expression patterns of the subunits of the CCR4-NOT deadenylase complex during neural development.

CNOT6L CNOT1

7.25e-05950221741365
Pubmed

The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.

KMT2D MEN1

7.25e-05950224930734
Pubmed

PIRs mediate innate myeloid cell memory to nonself MHC molecules.

LILRA1 LILRA2

9.05e-051050232381589
Pubmed

mTOR regulates the expression of DNA damage response enzymes in long-lived Snell dwarf, GHRKO, and PAPPA-KO mice.

CNOT6L CNOT1

9.05e-051050227618784
Pubmed

Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.

LILRA1 LILRA2

9.05e-051050218802077
Pubmed

CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma.

KMT2D PTCH1

9.05e-051050226290144
Pubmed

miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.

CNOT6L CNOT1

9.05e-051050221984185
Pubmed

Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity.

LILRA1 LILRA2

1.10e-041150221364532
Pubmed

Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression.

KMT2D MEN1

1.10e-041150218082152
Pubmed

Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase.

LILRA1 LILRA2

1.10e-041150220145200
Pubmed

Differential gene expression of the intermediate and outer interzone layers of developing articular cartilage in murine embryos.

LILRA1 LILRA2

1.10e-041150224738827
Pubmed

Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.

LILRA1 LILRA2

1.10e-041150224052308
Pubmed

Depletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growth.

CNOT6L CNOT1

1.32e-041250217452450
Cytoband19q13.4

LILRA1 LILRA2 LILRA6

9.07e-057950319q13.4
CytobandEnsembl 112 genes in cytogenetic band chr11q11

OR4A16 OR4A4P

8.83e-0440502chr11q11
Cytoband4q13.3

CNOT6L ANKRD17

9.73e-04425024q13.3
Cytoband11p11.12

OR4C13 OR4A4P

9.73e-044250211p11.12
CytobandEnsembl 112 genes in cytogenetic band chr13q13

FREM2 FRY

3.65e-0382502chr13q13
CytobandEnsembl 112 genes in cytogenetic band chr2q36

SLC16A14 DOCK10

3.92e-0385502chr2q36
CytobandEnsembl 112 genes in cytogenetic band chr2q32

FSIP2 DNAH7

6.47e-03110502chr2q32
GeneFamilyCD molecules|Activating leukocyte immunoglobulin like receptors

LILRA1 LILRA2 LILRA6

1.44e-0763631181
GeneFamilyOlfactory receptors, family 4

OR4A16 OR4A47 OR4C13 OR4A4P

1.22e-04129364151
GeneFamilyCCR4-NOT transcription complex

CNOT6L CNOT1

2.10e-04113621023
GeneFamilyAnkyrin repeat domain containing

ANKRD44 ANKS6 ANKRD17

1.22e-02242363403
GeneFamilySterile alpha motif domain containing

PHC3 ANKS6

1.33e-0288362760
GeneFamilyActins|Deafness associated genes

COL11A2 TECTA

2.12e-021133621152
CoexpressionERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN

FRY GPR27 SH3YL1

2.58e-0532473M40951
CoexpressionGSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN

KMT2D GPR27 APAF1 DOCK10 AQP9

2.91e-05200475M3510
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LILRA2 DSG3 LILRA6 TECTA AQP9

1.59e-06176505676839d07450b313222622e0ffd305c732cbad6d
ToppCell5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 GPR27 LILRA6 AQP9

1.87e-061825051fb9bdf2e9f0a9c230f109b471672f9c31e27c82
ToppCellCOVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 CNOT6L MAP4K1 DOCK10 STK39

2.25e-061895052c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 CNOT6L MAP4K1 DOCK10 STK39

2.37e-061915057f64add931b64b8d35836fa6bee9ebab593844d3
ToppCellURO|World / Disease, Lineage and Cell Type

LILRA1 LILRA2 NBEAL2 LILRA6 AQP9

2.50e-06193505421dc0996c6c973f88e90197b651255ae4dd13a2
ToppCellAdult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor

ANKRD44 CNOT6L DIPK1A MAP4K1 DOCK10

2.56e-061945055c1dca33f382f37a7deb23e573578343c3b54986
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 LILRA1 LILRA2 LILRA6 AQP9

2.63e-0619550510ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FREM2 SLC9C1 TECTA TMPRSS11A

2.12e-0514550496712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

ANKRD44 PHC3 CNOT6L DOCK10

3.28e-05162504b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

FSIP2 CNOT6L DNAH7 CYB561

3.52e-05165504436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

FSIP2 CNOT6L DNAH7 CYB561

3.52e-05165504242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

LILRA1 FRY GPR27 LILRA6

3.87e-05169504d4bd489ebdb86e70ed5e3dbbe8518c6cae2197e5
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LILRA2 DSG3 DOCK10 AQP9

3.96e-05170504be2a34c70665d8d11332b1a70eda03d77cb7f7dd
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

4.05e-05171504098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

4.14e-05172504cf46810dd1072b6f2171e5d9530351ddc79a055b
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

4.33e-0517450405d54a36772f096047521e16a89cc42ae48d2a1d
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FRY MTHFD1L APAF1 AQP9

4.43e-05175504334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

FRY MTHFD1L APAF1 AQP9

4.43e-05175504da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LILRA1 LILRA2 LILRA6 DOCK10

4.94e-0518050497241f62ee133dcb0d4855ffda5dd1349de9f7b2
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LILRA1 LILRA2 LILRA6 DOCK10

4.94e-0518050441896546cd1cc458e08c0d4e19aa4860e5d4fcd6
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SLC9C1 EPS8L2 MTHFD1L STK39

5.05e-05181504576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCellwk_08-11-Hematologic-Myeloid-Non-cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

5.38e-05184504324f91b70913bda3509e234aaf23b46fad91e076
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

5.50e-0518550400a991e63e9ac6de3f48a96e3be6073f90cbb442
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 CNOT6L MAP4K1 DOCK10

5.61e-051865049d576dce2c5deefef1adda16c6da7055c8d57f8f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 CNOT6L MAP4K1 DOCK10

5.61e-05186504bd3bd022b575d9b0ef90d50a5cb874085a827b77
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 MAP4K1 NBEAL2 DOCK10

5.61e-05186504305f1726b8b5add32f1c29c74991ff34f42e0da7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 CNOT6L MAP4K1 DOCK10

5.61e-05186504924cc357b4c4ce8e9b05773bdab544f0b65474cc
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

5.73e-05187504c20689022569640ebc4a878e3fe146b86fe9b386
ToppCelldroplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MTHFD1L DIPK1A LILRA6 DOCK10

5.73e-05187504028e7d6e1211e123879d2f353dc32fae1185dd8e
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SLC9C1 EPS8L2 NBEAL2 STK39

5.85e-0518850443a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCellLPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CNOT6L DIPK1A DOCK10 STK39

5.85e-05188504bbe65b1c11c88ab62d8485cfc3a913ff9da89aad
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 CNOT6L DIPK1A DOCK10

5.97e-05189504df30478b288084a1bd48f660409dcc784040897c
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 CNOT6L DIPK1A DOCK10

5.97e-05189504b87d586a9570fa54f3e0c6bd4731c5badcaedae6
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 CNOT6L DIPK1A DOCK10

5.97e-05189504823d6debd09e440ddf36c54af24a5f20e222a21e
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

5.97e-05189504984b5f21e84dd8273d8437ac2a5a9de4e9484b9a
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 CNOT6L DIPK1A DOCK10

5.97e-0518950447c2b419b081d5bf75da5e3d9a0e05a70362dfe7
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

5.97e-0518950474a5e61cd820f2495dde40e766c771a31d8c4e7d
ToppCellCOVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 CNOT6L DOCK10 STK39

5.97e-05189504b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA1 LILRA2 LILRA6 AQP9

6.10e-0519050457800d807785b9d539b47945a0a74631f5e88a06
ToppCellwk_20-22-Hematologic-Myeloid-Neutrophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

LILRA2 GPR27 LILRA6 AQP9

6.10e-051905045da4a90f56f66567614d84b9b437f559006ea51c
ToppCellPCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

6.10e-05190504b7ce76931edc6734b80ddbb2fca23b098a8c1352
ToppCellwk_08-11-Hematologic-Myeloid-DC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 MAP4K1 LILRA6

6.10e-05190504902afe2121593ae08d083c2cea2d1ba9f848574a
ToppCellCOVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD44 CNOT6L MAP4K1 DOCK10

6.22e-05191504543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD44 CNOT6L DIPK1A DOCK10

6.22e-0519150429ce21c6e810edd51f13e0fb1083cd44bd57b1d4
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA1 LILRA2 LILRA6 AQP9

6.22e-051915041c7d31684654ca6a046d8cc816af1fdc42369c57
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FREM2 FRY EPS8L2 DNAH7

6.22e-0519150460ff989fe99d243a3d52955223680cdd1f1917a4
ToppCellCOVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD44 CNOT6L MAP4K1 DOCK10

6.22e-051915045a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA1 LILRA2 LILRA6 AQP9

6.22e-05191504d60d81d2045c6e624bbc8b17e13a32f7921d969f
ToppCell5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

6.22e-051915041e668d67bc254ea15518e2c7a029a61087609b7a
ToppCellCOVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type

ANKRD44 CNOT6L MAP4K1 DOCK10

6.22e-0519150473ea3078c1f55cd47e4d99e77b3ce4ff17549d49
ToppCellPSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LILRA1 LILRA2 LILRA6 AQP9

6.35e-051925048dbdaa6a81767a866fb856f99ae35f9ee8064106
ToppCellPCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

6.35e-05192504d44f46352bac414b45cc749f7cbdc3a159bd7ae8
ToppCellmild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

LILRA2 GPR27 LILRA6 AQP9

6.35e-051925044cd8f572e067bf5fe22f62fa868d7d332f097a8c
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

6.35e-0519250462eac1b8aed4fb924946b58c0237313f697a0136
ToppCellPCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

6.35e-05192504aa65557b35d3eba9f24b970849255d05174d1c05
ToppCellPCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

6.35e-051925046ac7ba0ef7d1b4f85dc12fa3f0ebaddc57f214a5
ToppCellAdult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor

ANKRD44 CNOT6L MAP4K1 DOCK10

6.48e-0519350426df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCellCOVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type

ANKRD44 CNOT6L MAP4K1 DOCK10

6.48e-05193504780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

LILRA1 CDC42BPA LILRA6 AQP9

6.48e-0519350452f5b0fbb8ca706206c65e7edbb1ddbd380aebae
ToppCellCF-Lymphoid|CF / Disease state, Lineage and Cell class

CNOT6L DIPK1A MAP4K1 MICAL3

6.48e-0519350411de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCell5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

6.48e-05193504c0509798ce06da0ec725c0c7b5cc195455f2c29f
ToppCell390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells)

LILRA1 LILRA2 LILRA6 AQP9

6.48e-05193504a50ee6110ea272d9d9f41d48bb5d43711cc00a32
ToppCellPCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

6.48e-05193504b044fca95f519ff2ceb378afe40a95911931a29e
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FREM2 FRY EPS8L2 DNAH7

6.61e-051945046b286992d4bb56013c0ea5a7601d3476d806175a
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 CNOT6L DIPK1A DOCK10

6.61e-051945043d6f2d190dd50804afea299957cc44c2bb756134
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LILRA1 NBEAL2 LILRA6 AQP9

6.61e-05194504b191851b2287afc8c47320f5488fd22e2a454aa6
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FREM2 FRY EPS8L2 DNAH7

6.61e-05194504f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCellCOVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type

ANKRD44 CNOT6L MAP4K1 DOCK10

6.61e-051945042a144a1c2d537c8a59aa419206ddd96c23f0aeab
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LILRA1 LILRA2 LILRA6 AQP9

6.74e-051955041d58585557bf8e9ce4d514e128d3a902b526331d
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA1 LILRA2 LILRA6 AQP9

6.74e-0519550401da7115e38c280fb0baff2032b62bdb609bad5e
ToppCellCOVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type

ANKRD44 CNOT6L DOCK10 STK39

6.74e-051955043ab941a369e3815f338890b116dc77aefa054098
ToppCellAdult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor

ANKRD44 LILRA1 APAF1 DOCK10

6.74e-05195504ea24da6fea1487acb1e56c28c0649858cc0a12bd
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

6.74e-05195504aa3914e277918299dc7d2995c0c72288462ad43d
ToppCell390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells)

LILRA1 LILRA2 LILRA6 AQP9

6.74e-051955046f09bfd6394c10c90c23d130a18941bf490e1a8f
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LILRA1 LILRA2 LILRA6 AQP9

6.74e-05195504580ed65b4152483b642a7e7dbdf00d03588c46f6
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LILRA1 LILRA2 LILRA6 AQP9

6.88e-05196504f943519bff51c3094776fd45889dadf9062c8379
ToppCellBronchial_Biopsy-Immune-Dendritic_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

LILRA1 LILRA2 DOCK10 AQP9

6.88e-05196504bd828596c5b3fd5e4156f555e532f3de99d32f92
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

6.88e-0519650423e22dfb9f9aec17b83574295f889e75f46ded50
ToppCellwk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

6.88e-05196504aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2
ToppCell390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells)

LILRA1 LILRA2 LILRA6 AQP9

7.01e-0519750401f5f5c34e904cc0146e978cc05ed1cd86a41533
ToppCellCOVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class

LILRA1 LILRA2 LILRA6 AQP9

7.01e-0519750498d4107e457e7399a84439acd73bf8f59598971b
ToppCellfacs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FRY EPS8L2 COL11A2 CDC42BPA

7.01e-05197504ece0c17eb68f394b20e588c0b0626d3987a4dbbb
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LILRA1 NBEAL2 LILRA6 AQP9

7.01e-05197504e5a1e846bbfec234cb50c87c1f24beb43fce6856
ToppCellmyeloid-Monocyte|myeloid / Lineage, cell class and subclass

LILRA1 GPR27 LILRA6 AQP9

7.01e-051975046acf059cee6ba6bdeacc089b090d72336790972a
ToppCell10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

7.01e-0519750467f19dd30adb03300f04219d0295bc1c1788f626
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type

LILRA1 LILRA6 DOCK10 AQP9

7.01e-05197504a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LILRA1 LILRA2 LILRA6 AQP9

7.01e-05197504b91016249b3585aa3536e96af18e4f1b1d2d5ce4
ToppCellwk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

LILRA1 LILRA2 LILRA6 AQP9

7.01e-05197504e862561f61a1ae1ec858b34f8d9c9a7dc8894104
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LILRA1 LILRA2 LILRA6 AQP9

7.01e-05197504c34d0d11c5c6154988b41e00aea169090cb09785
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LILRA1 LILRA2 LILRA6 AQP9

7.01e-05197504ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9
ToppCellCOVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class

LILRA2 GPR27 LILRA6 AQP9

7.01e-05197504344801997b89bd81d8d5c3c872934de523233a8d
ToppCellfacs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FRY EPS8L2 COL11A2 CDC42BPA

7.01e-051975044b6c0e028b9669c102df8e9dc63e284f8d5fd9ee
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA1 LILRA2 LILRA6 AQP9

7.01e-05197504d9d58c2fe40d9b5b9031fb7a71525a535927effe
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

7.01e-05197504dcf0009057576a7db9065e644a3919d6de2ac8e6
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

LILRA1 LILRA6 DOCK10 AQP9

7.15e-05198504ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue

LILRA1 LILRA2 LILRA6 AQP9

7.15e-051985042541f1095ed91e6789cb888cf39a208b8107726a
ToppCellTracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LILRA1 LILRA2 LILRA6 AQP9

7.15e-051985044ba72ba1f0cebc93053aae72d763c33e155b6fa4
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD44 CNOT6L GPR27 DOCK10

7.15e-051985043c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5
ToppCellwk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

FREM2 FRY EPS8L2 CYB561

7.15e-051985041eb49b853a9e144e840c660060473fc7873f6478
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD44 MAP4K1 DOCK10 MICAL3

7.15e-05198504863765ccc0205dc28864dae85af339c283194c96
ComputationalGenes in the cancer module 430.

MAP4K1 NBEAL2 MEN1

4.67e-0455303MODULE_430
ComputationalNeighborhood of PECAM1

LILRA1 LILRA2 LILRA6

4.92e-0456303GNF2_PECAM1
ComputationalNeighborhood of TNFRSF1B

LILRA1 LILRA2 LILRA6

7.63e-0465303GNF2_TNFRSF1B
ComputationalNeighborhood of CARD15

LILRA1 LILRA2 LILRA6

9.47e-0470303GNF2_CARD15
Diseaseholoprosencephaly (is_implicated_in)

PTCH1 CNOT1

6.91e-058472DOID:4621 (is_implicated_in)
DiseaseConnective Tissue Diseases

COL11A2 ACVR1

1.92e-0413472C0009782
Diseasemacula measurement

CDC42BPA NSF STK39 PTCH1

2.34e-04189474EFO_0008375
Diseaseleukocyte immunoglobulin-like receptor subfamily B member 1 measurement

LILRA1 LILRA2

2.57e-0415472EFO_0008208
DiseaseNonsyndromic Deafness

EPS8L2 COL11A2 TECTA

2.96e-0481473C3711374
Diseasepancreatic cancer (is_marker_for)

APAF1 ACVR1 PTCH1

5.66e-04101473DOID:1793 (is_marker_for)
DiseaseHereditary Paraganglioma-Pheochromocytoma Syndrome

KMT2D MEN1

6.15e-0423472C1708353
Diseaselung squamous cell carcinoma (is_implicated_in)

KMT2D PTCH1

6.70e-0424472DOID:3907 (is_implicated_in)
Diseasecoronary artery calcification

FSIP2 FRY DOCK10 MICAL3 AQP9

7.31e-04450475EFO_0004723
DiseaseAutosomal dominant nonsyndromic hearing loss

COL11A2 TECTA

9.81e-0429472cv:C5779548

Protein segments in the cluster

PeptideGeneStartEntry
VIGGLIYVLVIEIHH

AQP9

256

O43315
IFLFDIHTSGLLGEI

APAF1

821

O14727
HLEVGLIILSVVFAV

ACVR1

121

Q04771
FGLHILEIGENSLIV

C1orf74

81

Q96LT6
ILAATAGHVGVVEIL

ANKRD17

1121

O75179
HIFALVIALVGLVAV

CYB561

91

P49447
RIHFGGLIEEDDVIL

MTHFD1L

306

Q6UB35
AGLVLVVLGILLFEA

LILRA2

456

Q8N149
LLSLVLGFVEHFLAV

MEN1

36

O00255
ALAIFVVVILVHGEL

DSG3

11

P32926
FLHIIVVILGLFGTI

NKAIN3

41

Q8N8D7
LILGIEIHVNVEFQG

MICAL3

171

Q7RTP6
GQILHVGGLFHLEDI

FREM2

881

Q5SZK8
DDLFQDLLVGVIHVL

FSIP2

3601

Q5CZC0
FLLLLAVVVGATHLV

GPR27

186

Q9NS67
IEHLLGGAEVFLLVV

OR4A16

101

Q8NH70
IEHIFGGSEVFLLLV

OR4A47

101

Q6IF82
HGVIIFGARILDEEV

COL11A2

186

P13942
LGANSGLHIIIFDEI

NSF

316

P46459
LVLVFLGILLFEAQH

LILRA6

456

Q6PI73
HVAAFLGDAEIIELL

ANKRD44

46

Q8N8A2
GEHFFRGVEVILLTV

OR4C13

101

Q8NGP0
ILTHVIEGFVIQEGL

PHC3

701

Q8NDX5
AELVHFLFGPLDLIV

EPS8L2

341

Q9H6S3
HFLIGILLREVGFAL

DOCK10

1151

Q96BY6
LGALVVLDVHARDVL

DNAH7

1236

Q8WXX0
HLGVVKLLLEAGAFV

ANKS6

156

Q68DC2
HALAGLFVEILVPVA

FRY

311

Q5TBA9
IHFEDFVVGLSILLR

KCNIP3

146

Q9Y2W7
IAIGLLEFVEDVFHG

DIPK1A

271

Q5T7M9
HFVDIIAGLAILFGA

ATP4A

301

P20648
FGLLGELLVALADHV

CCDC103

141

Q8IW40
IEHLFGGSEVFLLLV

OR4A4P

101

Q8NGN8
DQHLLLGAEEGIFIL

MAP4K1

511

Q92918
NIFELAITLIGILHV

SLC9C1

676

Q4G0N8
VLVVLGILLFEAQHS

LILRA1

471

O75019
IVHIFGKVILGVIAD

SLC16A14

361

Q7RTX9
HVLVGLEDGKLIVVV

NBEAL2

2701

Q6ZNJ1
GFEIGIEVSDLVIIL

SH3YL1

91

Q96HL8
LALGVGVDDVFLLAH

PTCH1

506

Q13635
IALGNEEGLFVVHVT

CDC42BPA

1241

Q5VT25
IGVAVVLEVHKELFG

CNOT6L

326

Q96LI5
GGFQDIAIEVLHLLL

CNOT1

171

A5YKK6
VLGIVVGVLLQDHDV

CNOT1

1966

A5YKK6
VGVFVVGADATHLIL

TECTA

1961

O75443
EHGVLFLVRELLNVI

VPS35L

791

Q7Z3J2
FLVAVHELGHALGLE

MMP16

241

P51512
VLFGINEFVLLHLLG

RHBG

161

Q9H310
EVAHALLDIFTIIGA

ZBED9

416

Q6R2W3
LFSAGLVDGHDVVIV

STK39

486

Q9UEW8
VAVTIGLLVHFLVFD

TMPRSS11A

31

Q6ZMR5
EELFGLTVHAVLRIA

KMT2D

5291

O14686
LLQVAVEGHVFLLDV

EXD3

416

Q8N9H8